BioVaxys Technology Corp.
BioVaxys Technology Corp.
BioVaxys Technology Corp. est une société d'immunothérapie au stade clinique développant des plates-formes vaccinales contre le SRAS-CoV-2 et divers cancers.
BioVaxys Technology Corp. (BIOV)
BioVaxys Technology Corp. (BIOV)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
National Bank Financial Inc. | 2,000 | 0.05 | 0.055 | 6,000 | RBC Capital Markets |
CIBC World Markets Inc. | 50,000 | 0.045 | 0.055 | 75,000 | National Bank Financial Inc. |
CIBC World Markets Inc. | 100,000 | 0.045 | 0.06 | 70,000 | Anonymous |
TD Securities Inc. | 35,000 | 0.045 | 0.06 | 80,000 | Anonymous |
National Bank Financial Inc. | 11,000 | 0.045 | 0.06 | 10,000 | TD Securities Inc. |
CIBC World Markets Inc. | 15,000 | 0.04 | 0.06 | 80,000 | Anonymous |
Questrade Inc. | 70,000 | 0.04 | 0.06 | 1,000 | National Bank Financial Inc. |
CIBC World Markets Inc. | 50,000 | 0.04 | 0.06 | 1,000 | National Bank Financial Inc. |
CIBC World Markets Inc. | 10,000 | 0.04 | 0.06 | 1,000 | National Bank Financial Inc. |
CIBC World Markets Inc. | 50,000 | 0.04 | 0.06 | 26,000 | National Bank Financial Inc. |
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
Anonymous | 20,000 | 0.04 | 0.00 | 0 | |
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
1 | 2,000 | 0.05 | 0.055 | 81,000 | 2 |
4 | 196,000 | 0.045 | 0.06 | 329,000 | 9 |
7 | 205,000 | 0.04 | 0.065 | 196,000 | 17 |
6 | 130,000 | 0.035 | 0.07 | 298,000 | 8 |
2 | 75,000 | 0.03 | 0.075 | 205,000 | 2 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
1 | 20,000 | 0.04 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
---|---|---|---|---|---|---|
Mar 12, 19:34 | 0.055 | 0.00 | 9,000 | CIBC World Markets Inc. | Anonymous | CSE |
Mar 12, 19:34 | 0.0525 | -0.0025 | 5,000 | CIBC World Markets Inc. | National Bank Financial Inc. | CSE |
Mar 12, 19:34 | 0.055 | 0.00 | 23,000 | CIBC World Markets Inc. | CIBC World Markets Inc. | CSE |
Mar 12, 19:34 | 0.055 | 0.00 | 1,000 | CIBC World Markets Inc. | Anonymous | CSE |
Mar 12, 19:34 | 0.055 | 0.00 | 2,000 | CIBC World Markets Inc. | TD Securities Inc. | CSE |
Information d'entreprise
SEDAR Information
Information d'entreprise
Capitalisation
Company Officers
Bulletins
2024-0715 - Réintégration - BioVaxys Technology Corp. (BIOV)
le 16 juillet/July 2024
Effective immediately, BioVaxys Technology Corp. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec effet immédiat, BioVaxys Technology Corp. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.